In a cluster-randomised trial of 318 patients aged ≥75 with hyperpolypharmacy, a pharmacist deprescribing-focused medication review vs usual care deprescribed more drugs (mean 2.5 vs 1.7) at 6 months, with no difference in total medications or quality of life.
RCTn = 318
Baas et al. Deprescribing in older patients with hyperpolypharmacy: a cluster-randomised trial in primary care